These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31577161)

  • 1. Aneurysm-type plexiform lesions form in supernumerary arteries in pulmonary arterial hypertension: potential therapeutic implications.
    Oshima K; Crockett ES; Joshi SR; McLendon JM; Matsumoto Y; McMurtry IF; Abe K; Oka M
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L805-L815. PubMed ID: 31577161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and pathogenesis of plexiform lesion in pulmonary hypertension.
    Ogata T; Iijima T
    Chin Med J (Engl); 1993 Jan; 106(1):45-8. PubMed ID: 8504682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hypoxia does not cause wall thickening of intra-acinar pulmonary supernumerary arteries.
    Oshima K; McLendon JM; Wagner WW; McMurtry IF; Oka M
    Physiol Rep; 2016 Feb; 4(2):. PubMed ID: 26811053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.
    Toba M; Alzoubi A; O'Neill KD; Gairhe S; Matsumoto Y; Oshima K; Abe K; Oka M; McMurtry IF
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H243-50. PubMed ID: 24240870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
    Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
    J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.
    White RJ; Meoli DF; Swarthout RF; Kallop DY; Galaria II; Harvey JL; Miller CM; Blaxall BC; Hall CM; Pierce RA; Cool CD; Taubman MB
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L583-90. PubMed ID: 17586694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension.
    Abe K; Shinoda M; Tanaka M; Kuwabara Y; Yoshida K; Hirooka Y; McMurtry IF; Oka M; Sunagawa K
    Cardiovasc Res; 2016 Jul; 111(1):16-25. PubMed ID: 27037259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.
    Patel M; Predescu D; Bardita C; Chen J; Jeganathan N; Pritchard M; DiBartolo S; Machado R; Predescu S
    Am J Pathol; 2017 Mar; 187(3):528-542. PubMed ID: 28068512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
    Abe K; Toba M; Alzoubi A; Ito M; Fagan KA; Cool CD; Voelkel NF; McMurtry IF; Oka M
    Circulation; 2010 Jun; 121(25):2747-54. PubMed ID: 20547927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.
    Dieffenbach PB; Mallarino Haeger C; Rehman R; Corcoran AM; Coronata AMF; Vellarikkal SK; Chrobak I; Waxman AB; Vitali SH; Sholl LM; Padera RF; Lagares D; Polverino F; Owen CA; Fredenburgh LE
    Am J Respir Crit Care Med; 2021 Dec; 204(12):1433-1451. PubMed ID: 34550870
    [No Abstract]   [Full Text] [Related]  

  • 15. TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
    Alzoubi A; Almalouf P; Toba M; O'Neill K; Qian X; Francis M; Taylor MS; Alexeyev M; McMurtry IF; Oka M; Stevens T
    Am J Pathol; 2013 Dec; 183(6):1779-1788. PubMed ID: 24113457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
    Ivy DD; McMurtry IF; Colvin K; Imamura M; Oka M; Lee DS; Gebb S; Jones PL
    Circulation; 2005 Jun; 111(22):2988-96. PubMed ID: 15927975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plexiform Arteriopathy in Rodent Models of Pulmonary Arterial Hypertension.
    Carman BL; Predescu DN; Machado R; Predescu SA
    Am J Pathol; 2019 Jun; 189(6):1133-1144. PubMed ID: 30926336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Tracking Suggests Pathophysiological and Therapeutic Role of Bone Marrow Cells in Sugen5416/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
    Miwa H; Sakao S; Sanada TJ; Suzuki H; Hata A; Shiina Y; Kobayashi T; Kato F; Nishimura R; Tanabe N; Voelkel N; Yoshino I; Tatsumi K
    Can J Cardiol; 2021 Jun; 37(6):913-923. PubMed ID: 33609715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.